Clinical Trials Browser

Phase NA × Prostatic Neoplasms × Protein Subunit Vaccines × Clear all

NCT00694551 2019-10-04

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Phase NA Completed

29 enrolled 7 charts

Prostatic Neoplasms